# The Response to Atropine Drops (RAD) Study

> **NCT05199597** · EARLY_PHASE1 · COMPLETED · sponsor: **Ohio State University** · enrollment: 30 (actual)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** 0.01% atropine
- **DRUG:** 0.05% atropine
- **DRUG:** 0.05% atropine
- **DRUG:** 0.05% atropine

## Key facts

- **NCT ID:** NCT05199597
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-19
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199597, "The Response to Atropine Drops (RAD) Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05199597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*